Enterin

Last Updated Mar 26, 2025

Company Overview

Company Name

Enterin

About Enterin

Enterin is a company focused on developing a novel drug to repair the dysfunctional gut-brain axis in patients with neurodegenerative diseases. Their lead molecule, ENT-01, has recently met its primary endpoint in a Phase 2b study for Parkinson's disease, indicating the potential to improve quality of life by influencing non-motor symptoms.

More Companies in California

Browse all companies in California

Frequently Asked Questions about Enterin

Advertising Pixels

  • LinkedIn Ad Pixel

Technologies Used

Key Decision Makers

Susan Lingelbach Senior CRA
LinkedIn